Methylprednisolone Sodium Succinate With Endovascular ThRombectomy for Large Ischemic STroke

NANot yet recruitingINTERVENTIONAL
Enrollment

912

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2029

Conditions
Ischemic Stroke, Acute
Interventions
DRUG

Methylprednisolone sodium succinate

"Intravenous methylprednisolone sodium succinate will be administered at a dose of 2 mg/kg/day for 3 days, with a maximum daily dose of 160 mg (4 vials, 40 mg/vial).~It is recommended that the initial dose be administered as soon as possible after randomization."

DRUG

Placebo

Matched intravenous placebo will be administered for 3 days, with a maximum daily dose of 4 vials.

Trial Locations (1)

510120

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou

All Listed Sponsors
lead

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER

NCT07175649 - Methylprednisolone Sodium Succinate With Endovascular ThRombectomy for Large Ischemic STroke | Biotech Hunter | Biotech Hunter